Opko Health [OPK] vs Danaher [DHR] Detailed Stock Comparison

Opko Health Inc.

NASDAQ
Loading...

Danaher Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Opko Health Inc. wins in 6 metrics, Danaher Corporation wins in 13 metrics, with 0 ties. Danaher Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Opko Health Inc. Danaher Corporation Better
P/E Ratio (TTM) -4.08 34.61 Danaher Corporation
Price-to-Book Ratio 0.73 2.40 Opko Health Inc.
Debt-to-Equity Ratio 31.29 37.17 Opko Health Inc.
PEG Ratio 0.01 3.84 Opko Health Inc.
EV/EBITDA -7.53 17.69 Danaher Corporation
Profit Margin (TTM) -37.19% 14.89% Danaher Corporation
Operating Margin (TTM) -28.98% 22.94% Danaher Corporation
EBITDA Margin (TTM) N/A 22.94% N/A
Return on Equity -17.14% 7.08% Danaher Corporation
Return on Assets (TTM) -6.62% 4.19% Danaher Corporation
Free Cash Flow (TTM) $-190.82M $5.26B Danaher Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return 6.77% -10.25% Opko Health Inc.
Price-to-Sales Ratio (TTM) 1.54 5.10 Opko Health Inc.
Enterprise Value $958.44M $140.38B Danaher Corporation
EV/Revenue Ratio 1.58 5.67 Opko Health Inc.
Gross Profit Margin (TTM) 43.13% 60.34% Danaher Corporation
Revenue per Share (TTM) $1 $35 Danaher Corporation
Earnings per Share (Diluted) $-0.30 $5.16 Danaher Corporation
Beta (Stock Volatility) 1.49 0.99 Danaher Corporation
Short % of Float 7.79% 1.10% Danaher Corporation

Opko Health Inc. vs Danaher Corporation Stock Performance Analysis

Loading Price Chart...

OPK
DHR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Opko Health Inc.-1.41%-2.10%27.27%17.65%3.70%10.24%
Danaher Corporation0.56%-1.32%11.85%-5.38%-20.75%-21.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Opko Health Inc.6.77%-8.39%-61.62%-84.31%-56.84%246.34%
Danaher Corporation-10.25%-15.98%-20.94%174.08%416.93%738.84%

Performance & Financial Health Analysis: Opko Health Inc. vs Danaher Corporation

MetricOPKDHR
Market Information
Market Cap i$936.60M$126.39B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,018,1605,174,666
90 Day Avg. Volume i2,439,2574,357,215
Last Close$1.40$181.10
52 Week Range$0.98 - $1.60$160.93 - $242.80
% from 52W High-12.50%-25.41%
All-Time High$19.20 (Jun 01, 2015)$296.06 (Sep 06, 2021)
% from All-Time High-92.71%-38.83%
Growth Metrics
Quarterly Revenue Growth-0.19%0.04%
Quarterly Earnings Growth-0.19%0.08%
Financial Health
Profit Margin (TTM) i-0.37%0.15%
Operating Margin (TTM) i-0.29%0.23%
Return on Equity (TTM) i-0.17%0.07%
Debt to Equity (MRQ) i31.2937.17
Cash & Liquidity
Book Value per Share (MRQ)$1.67$74.32
Cash per Share (MRQ)$0.48$8.06
Operating Cash Flow (TTM) i$-178,542,000$6.44B
Levered Free Cash Flow (TTM) i$-131,252,376$4.57B
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$1.28

Valuation & Enterprise Metrics Analysis: Opko Health Inc. vs Danaher Corporation

MetricOPK (Apr 24, 2026)DHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-4.0834.61
Forward P/E i-3.7019.64
PEG Ratio i0.013.84
Price to Sales (TTM) i1.545.10
Price to Book (MRQ) i0.732.40
Market Capitalization
Market Capitalization i$936.60M$126.39B
Enterprise Value i$958.44M$140.38B
Enterprise Value Metrics
Enterprise to Revenue i1.585.67
Enterprise to EBITDA i-7.5317.69
Risk & Other Metrics
Beta i1.490.99
Book Value per Share (MRQ) i$1.67$74.32

Financial Statements Comparison: Opko Health Inc. vs Danaher Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOPK (2025)DHR (2025)
Revenue/Sales i606.88M24.57B
Cost of Goods Sold i400.94M10.05B
COGS % of Revenue i66.1%40.9%
Gross Profit i205.94M14.52B
Gross Margin i33.9%59.1%
Research & Development i124.03M1.60B
Operating Income (EBIT) i-218.99M4.69B
Operating Margin i-36.1%19.1%
EBITDA i-142.42M7.17B
EBITDA Margin i-23.5%29.2%
Pre-Tax Income i-241.36M4.23B
Pre-Tax Income % of Revenue i-39.8%17.2%
Income Tax i-15.71M633.00M
Income Tax % of Revenue i-2.6%2.6%
Net Income (Profit) i-225.68M3.61B
Profit Margin i-37.2%14.7%

Balance Sheet & Liquidity Metrics

MetricOPK (2025)DHR (2025)
Cash & Equivalents i369.07M4.62B
Total Current Assets i581.88M12.76B
Total Current Assets % of Revenue i95.9%51.9%
Total Current Liabilities i146.68M6.81B
Total Current Liabilities % of Revenue i24.2%27.7%
Long-Term Debt i373.92M19.50B
Long-Term Debt % of Revenue i61.6%79.4%
Total Shareholders Equity i1.27B52.54B
Retained Earnings i-2.29B46.89B
Retained Earnings % of Revenue i-377.5%190.9%
Property, Plant & Equipment i46.93M2.14B

Cash Flow Statement Comparison

MetricOPK (2025)DHR (2025)
Operating Cash Flow i-60.19M5.64B
Operating Cash Flow % of Revenue i-9.9%23.0%
Capital Expenditures i287,000-1.12B
Free Cash Flow i-190.82M5.26B
FCF Margin i-31.4%21.4%
Debt Repayment i-103.79M-500.00M
Common Stock Repurchase i-47.04M-3.09B

Short Interest & Institutional Ownership Analysis

MetricOPKDHR
Shares Short i33.62M6.94M
Short Ratio i12.741.68
Short % of Float i7.79%1.10%
Shares Outstanding i759.07M707.70M
Float Shares i336.30M630.65M
% Held by Insiders i49.35%10.78%
% Held by Institutions i27.03%85.08%
% Held by Public i23.62%4.14%

Dividend Analysis & Yield Comparison: Opko Health Inc. vs Danaher Corporation

MetricOPKDHR
Last 12-Month Dividend iN/A$1.28
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$10.51
3-Year Avg Dividend Yield iN/A1.11%
3-Year Total Dividends iN/A$31.54
Ex-Dividend DateN/ADec 26, 2025